Table 3.
Nefopam (n = 22) | Ketamine (n = 22) | Control (n = 21) | P | |
---|---|---|---|---|
Nausea or Vomiting | 12 | 8 | 4 | NS |
Tachycardia | 8 | 2 | 3 | < 0.005 |
Profuse Sweating | 4 | 0 | 0 | < 0.05 |
Dry Mouth | 4 | 0 | 1 | NS |
Dysphoria | 0 | 1 | 0 | NS |
Diplopia | 0 | 2 | 2 | NS |
Dizziness | 1 | 4 | 1 | NS |
Results presented as number of patients. Tachycardia and profuse sweating were most frequent in the Nefopam group.